Brian Kenneth Roberts M.D.
Net Worth

Last updated:

What is Brian Kenneth Roberts M.D. net worth?

The estimated net worth of Dr. Brian Kenneth Roberts M.D. is at least $2,242,861 as of 14 Jun 2024. He owns shares worth $8,641 as insider and has received compensation worth at least $2,234,220 in Rezolute, Inc..

What is the salary of Brian Kenneth Roberts M.D.?

Dr. Brian Kenneth Roberts M.D. salary is $744,740 per year as Senior Vice President & Head of Clinical Devel. in Rezolute, Inc..

How old is Brian Kenneth Roberts M.D.?

Dr. Brian Kenneth Roberts M.D. is 50 years old, born in 1975.

What stocks does Brian Kenneth Roberts M.D. currently own?

As insider, Dr. Brian Kenneth Roberts M.D. owns shares in one company:

Company Title Shares Price per share Total value
Rezolute, Inc. (RZLT) Senior Vice President & Head of Clinical Devel. 1,376 $6.28 $8,641

What does Rezolute, Inc. do?

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

RZLT logo
RZLT
Rezolute, Inc.
$6.28

Brian Kenneth Roberts M.D. insider trading

Rezolute, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Shares 300 $3.96 $1,188
Purchase
Common Shares 4,000 $3.91 $15,640
Purchase
Common Shares 300 $3.97 $1,191
Purchase
Common Shares 3,000 $3.91 $11,724
Purchase
Common Shares 500 $2.55 $1,275
Purchase
Common Shares 10,000 $1.88 $18,800
Purchase
Common Shares 500 $1.85 $925
Purchase
Common Shares 500 $1.85 $925
Purchase
Common Shares 2,000 $1.7 $3,400
Purchase
Common Shares 6,000 $1.69 $10,140
Purchase
Common Shares 7,000 $1.31 $9,142
Purchase
Common Stock 300 $2.95 $884
Purchase
Common Stock 200 $2.86 $572
Purchase
Common Stock 1,000 $3.41 $3,407
Purchase
Common Stock 21,052 $3.8 $79,998

Rezolute key executives

Rezolute, Inc. executives and other stock owners filed with the SEC: